(Q36676445)

15 August 2017

1 reference

title

Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders (English)

1 reference

15 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

1

Brogden RN

1 reference

15 August 2017

McTavish D

2

1 reference

15 August 2017

1 June 1991

1 reference

15 August 2017

1 reference

15 August 2017

41

1 reference

15 August 2017

6

1 reference

15 August 2017

927-940

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199141060-00008

15 August 2017

0 references

cites work

French multicentre double-blind study to evaluate the efficacy and safety of acrivastine as compared with terfenadine in seasonal allergic rhinitis

1 reference

12 December 2020

Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers

1 reference

12 December 2020

Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy

1 reference

12 December 2020

Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria.

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamine

1 reference

12 December 2020

Quantitative gas chromatographic-mass spectrometric analysis of acrivastine and a metabolite in human plasma

1 reference

12 December 2020

Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis

1 reference

12 December 2020

Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy

1 reference

12 December 2020

A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria

1 reference

12 December 2020

The effects of acrivastine (BW825C), diphenhydramine and terfenadine in combination with alcohol on human CNS performance.

1 reference

12 December 2020

The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects.

1 reference

12 December 2020

Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

12 December 2020

A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria

1 reference

12 December 2020

A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria

1 reference

12 December 2020

Failure of terfenadine in relieving the pruritus of atopic dermatitis

1 reference

12 December 2020

Prolonged treatment with acrivastine for seasonal allergic rhinitis

1 reference

12 December 2020

Mechanism of action of antipruritic drugs

1 reference

12 December 2020

Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy

1 reference

12 December 2020

Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Treatment of bronchial asthma with terfenadine; a randomized controlled trial

1 reference

12 December 2020

The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers

1 reference

12 December 2020

Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study

1 reference

12 December 2020

Pharmacokinetics of acrivastine after oral and colonic administration

1 reference

12 December 2020

A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis

1 reference

12 December 2020

A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria

1 reference

12 December 2020

Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study

1 reference

12 December 2020

Acrivastine in allergic rhinitis: a review of clinical experience.

1 reference

12 December 2020

Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double-blind, placebo-controlled study

1 reference

12 December 2020

Cetirizine in pollen-associated asthma

1 reference

12 December 2020

Acrivastine in seasonal allergic rhinitis: two randomized crossover studies to evaluate efficacy and safety

1 reference

12 December 2020

Treatment of itching in atopic eczema with antihistamines with a low sedative profile

1 reference

12 December 2020

Acrivastine--an evaluation of initial and peak activity in human skin

1 reference

12 December 2020

An assessment of the novel antihistamine BW 825C in the treatment of chronic idiopathic urticaria. A placebo-controlled study.

1 reference

12 December 2020

10.2165/00003495-199141060-00008

Identifiers

DOI

1 reference

PubMed ID

1715267

Dimensions Publication ID

15 August 2017

0 references

1 reference

PubMed ID

1715267